PRESCRIPTION USE BLOOD GLUCOSE METER FOR NEAR-PATIENT TESTING

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-03-23 for PRESCRIPTION USE BLOOD GLUCOSE METER FOR NEAR-PATIENT TESTING manufactured by Nova Biomedical Corporation.

Event Text Entries

[184517044] Upon pt's arrival to ed. Pt's blood glucose (bg) level checked using glucometer. Bg on glucometer read 47. Pt treated with d50 per emergency dept provider by primary rn 10 minutes later. Comprehensive metabolic panel collected immediately after bg was checked with glucometer, resulted and showed glucose to be 75. To confirm, 2 hours later glucose confirmatory done within 5 minutes of blood glucose fingerstick to show glucose of 85. Glucometer showed 60 from fingerstick. Point of care technician (poct) called. Per poct, ok to take glucometer out of service and call biomed. Charge notified.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9866689
MDR Report Key9866689
Date Received2020-03-23
Date of Report2020-03-11
Date of Event2019-12-28
Report Date2020-03-11
Date Reported to FDA2020-03-11
Date Reported to Mfgr2020-03-23
Date Added to Maude2020-03-23
Event Key0
Report Source CodeUser Facility report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationRISK MANAGER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Generic NamePRESCRIPTION USE BLOOD GLUCOSE METER FOR NEAR-PATIENT TESTING
Product CodePZI
Date Received2020-03-23
Device Availability*
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerNOVA BIOMEDICAL CORPORATION
Manufacturer Address200 PROSPECT ST WALTHAM MA 02454 US 02454


Patients

Patient NumberTreatmentOutcomeDate
10 2020-03-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.